Literature DB >> 11123758

Corresponding distributions of increased endothelin-B receptor expression and increased endothelin-1 expression in the aorta of apolipoprotein E-deficient mice with advanced atherosclerosis.

T Kobayashi1, T Miyauchi, S Iwasa, S Sakai, J Fan, M Nagata, K Goto, T Watanabe.   

Abstract

Endothelin (ET)-1 causes proliferation of vascular smooth muscle cells (VSMC). Although it has been reported that stimulation of ET(B) receptors as well as ET(A) receptors promote proliferation of VSMC, the precise distribution of each receptor subtype in atherosclerotic vessels is unknown. Previous studies demonstrated that apolipoprotein E (apoE)-deficient mice have hypercholesterolaemia and develop severe atherosclerosis. To investigate the pathophysiological roles of vascular ET system in atherosclerosis, we examined preproET-1 messenger ribonucleic acid expression in the aorta of apoE-deficient mice, and performed immunohistochemical staining for ET-1 and each ET receptor subtype (ET(A) and ET(B) receptors) in the atherosclerotic lesions of these mice. The level of preproET-1 mRNA in the aorta was significantly higher in the apoE-deficient mice than in the control mice. Strong ET-1 staining was observed in the macrophage-foam cells, intimal and medial VSMC in the atherosclerotic lesions of the apoE-deficient mice. In addition, in the atherosclerotic lesions, strong ET(B) receptor staining was observed in the macrophage-foam cells, intimal and medial VSMC, which distribution corresponded closely to that of ET-1. ET(A) receptor staining was observed in the medial VSMC of both groups, but not in the macrophage-foam cells of the apoE-deficient mice. ET(A) receptor staining in the medial VSMC was stronger in the apoE-deficient mice than in the control mice. These results suggest that the vascular ET system, including ET-1 and ET receptors, is activated in the atherosclerotic lesions of apoE-deficient mice. Since the distribution of strong ET(B) receptor staining corresponded closely to that of ET-1, it is suggested that the ET system, mediated by ET(B) receptors, has an important role in the pathophysiology of the atherosclerotic lesions of apoE-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123758     DOI: 10.1046/j.1440-1827.2000.01152.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  14 in total

1.  Alterations in nitric oxide and endothelin-1 bioactivity underlie cerebrovascular dysfunction in ApoE-deficient mice.

Authors:  Kazuo Yamashiro; Alexandra B Milsom; Johan Duchene; Catherine Panayiotou; Takao Urabe; Nobutaka Hattori; Amrita Ahluwalia
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-17       Impact factor: 6.200

2.  Agonist-promoted ubiquitination differentially regulates receptor trafficking of endothelin type A and type B receptors.

Authors:  Koji Terada; Takahiro Horinouchi; Yoichiro Fujioka; Tsunehito Higashi; Prabha Nepal; Mika Horiguchi; Sarita Karki; Chizuru Hatate; Akimasa Hoshi; Takuya Harada; Yosuke Mai; Yusuke Ohba; Soichi Miwa
Journal:  J Biol Chem       Date:  2014-11-07       Impact factor: 5.157

3.  Vehicular Particulate Matter (PM) Characteristics Impact Vascular Outcomes Following Inhalation.

Authors:  Katherine E Zychowski; Christina R Steadman Tyler; Bethany Sanchez; Molly Harmon; June Liu; Hammad Irshad; Jacob D McDonald; Barry E Bleske; Matthew J Campen
Journal:  Cardiovasc Toxicol       Date:  2020-06       Impact factor: 3.231

4.  Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart.

Authors:  Adrian T Gonon; Alexander Bulhak; Anders Bröijersén; John Pernow
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

Review 5.  Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease.

Authors:  Marc Q Mazzuca; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2012-03-30       Impact factor: 5.858

6.  The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance.

Authors:  David Vicent; Jacob Ilany; Tatsuya Kondo; Keiko Naruse; Simon J Fisher; Yaz Y Kisanuki; Sven Bursell; Masashi Yanagisawa; George L King; C Ronald Kahn
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

7.  Pathogenesis of atherosclerosis: A multifactorial process.

Authors:  Raja B Singh; Sushma A Mengi; Yan-Jun Xu; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2002

8.  Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease.

Authors:  Ivan Dimitrijevic; Marie-Louise Edvinsson; Qingwen Chen; Malin Malmsjö; Per-Ola Kimblad; Lars Edvinsson
Journal:  BMC Cardiovasc Disord       Date:  2009-08-25       Impact factor: 2.298

9.  Minimally modified LDL upregulates endothelin type A receptors in rat coronary arterial smooth muscle cells.

Authors:  Jie Li; Lei Cao; Cang-Bao Xu; Jun-Jie Wang; Yong-Xiao Cao
Journal:  Mediators Inflamm       Date:  2013-06-19       Impact factor: 4.711

10.  Pathological Importance of the Endothelin-1/ET(B) Receptor System on Vascular Diseases.

Authors:  Kento Kitada; Mamoru Ohkita; Yasuo Matsumura
Journal:  Cardiol Res Pract       Date:  2012-07-30       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.